TrialCancer chemotherapy and pharmacology2015

Phase I/II study of gefitinib (Iressa(®)) and vorinostat (IVORI) in previously treated patients with advanced non-small cell lung cancer.

Ji-Youn Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.